CPF Logo
 
 Coalition for Pulmonary Fibrosis
Suite F, #227
1659 Branham Lane
San Jose, CA 95118-5226
(888) 222-8541
info@coalitionforpf.org
  
SEARCH:   
Join the Fight
 
the pressroom
 
media archive
 
calendar of events
 
contribute today
 
act
 
fundraiser
 
butterfly ball
 
announcments
 

 
News & Events:
 
Recent IPF News & Announcements

News Archive:  2008  2007  2006  2005  2004  2003  2002  2001  
 
August 12, 2008 CPF Publishes 3rd Quarter, 2008 Action Alert Newsletter
August 11, 2008 Gilead to Initiate Phase III Clinical Trial of Letairis in IPF
July 31, 2008 Exploratory Study of Enbrel (etanercept) in IPF Shows Possible Reduction in Progression of Disease
July 22, 2008 Pulmonary Fibrosis Research Enhancement Act of 2008 Introduced in U.S. Congress
Landmark Bill Would Create National Patient Registry, Increase Public Awareness of Deadly Lung Disease
July 16, 2008 Senate Passes Key Medicare Bill that Includes Pulmonary Rehabilitation Coverage Provision and Repeals Key Home Oxygen Statute
July 14, 2008 Study Finds Sleep Quality Impacts Quality of Life for IPF Patients
June 27, 2008 ALA Report Finds Lung Disease Mortality Rates Increasing
June 23, 2008 CPF Chairman Marvin Schwarz, MD Discusses IPF Research with BioWorld Today Reporter
Rare Pulmonary Fibrosis may Have Blockbuster Potential By Catherine Hollingsworth, BioWorld Today
June 14, 2008 Rep. Brian Baird (D- WA) Discusses PF Research Enhancement Act of 2008 with KPOJ radio (Portland, OR)
June 11, 2008 CPF Publishes 2nd Quarter, 2008 Action Alert Newsletter
June 03, 2008 2008 National IPF Awareness Week to Be Held September 7-13
Meet with Congressional Members in Your District, Write Letters, Hold a Local Event to Celebrate IPF Week and Spread the Word about IPF
May 21, 2008 Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
CPF and ATS to Jointly Award $200,000 in research funding
May 19, 2008 InterMune Initiates Roll-Over Study of Pirfenidone in IPF
May 19, 2008 Pirfenidone Gets Fast-Track Designation From FDA
May 18, 2008 CPF Chairman Marvin Schwarz, MD Receives Top Honor from American Thoracic Society
May 12, 2008 Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for IPF
One-Year Phase I/II Clinical Trial in Refractory IPF Patients Already Completed by Leading IPF Clinical Research Group
April 25, 2008 Genetic Information Nondiscrimination Act (GINA) Passes Congress
March 15, 2008 CPF Joins ATS on Capitol Hill to Advocate for Lung Disease Issues
February 27, 2008 University of Minnesota Researchers Find Lung Transplant Survival, Major Complications Not Affected by Use of New Lung Allocation Scoring (LAS) System
February 20, 2008 CPF Publishes 1st Quarter, 2008 Action Alert Newsletter
February 19, 2008 Coalition for Pulmonary Fibrosis and National Jewish Medical and Research Center Collaborate to Provide Genetic Counseling for Familial Pulmonary Fibrosis Patients
Genetic Counseling, Medical Information, and Support Program First of its Kind in U.S.
January 28, 2008 Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row
Deadly Lung Disease Claims as Many Lives Each Year as Breast Cancer, Yet Largely Unknown
January 22, 2008 Coalition For Pulmonary Fibrosis and American Thoracic Society Awards $100,000 Pulmonary Fibrosis Grant to Massachusetts General Hospital Researcher
CPF and ATS Jointly Fund Two-Year Study Investigating Key Trigger of Lung Injury
January 21, 2008 CPF Appoints Mishka Michon Chief Executive Officer
January 18, 2008 Hollywood Takes Notice of Little Known Deadly Lung Disease
Recent Deaths of Well-Known Celebrities, Hit TV Shows Help Spread the Word About Pulmonary Fibrosis
January 18, 2008 Rare Lung Disease Cells Indicate Higher Mortality Risk

 
 
 
 

  All registered trademarks and trademarks that appear in this Web site are the
property of their respective owners. ©2001 - 2008 Coalition for Pulmonary Fibrosis
Site Last Updated 8/4/08
floor 84 studio

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.